Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance

• Published in: Facts, views & vision in ObGyn Vol. 5; no. 2; pp. 106 - 115
• Main Authors: Göker, M, Devoogdt, N, Van de Putte, G, Schobbens, J C, Vlasselaer, J, Van den Broecke, R, de Jonge, E T M
• Format: Journal Article
• Language: English
• Published: Belgium Universa Press 01.01.2013
• Subjects: Systematic Review; prevalence; Breast cancer; definition; lymphoedema; incidence; axillary lymph node dissection
• ISSN: 2032-0418

Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer treatment varies due to a lack of -uniform definition and measurement criteria. This review aims to determine the prevalence of BCRL following axillary lymph node dissection (ALND) as a benchmark to be used in a risk-benefit medical decision whether to proceed with ALND or not. The risk of leaving unresected non-sentinel metastatic lymph nodes with a presumed inherent risk of local recurrence will be balanced against the risk of BCRL following a potentially unnecessary ALND. Pubmed and Embase databases were searched for all publications on BCRL in order to estimate its -incidence and to decide on the most appropriate measurement method to use in clinical practice. 51 articles were identified on BCRL incidence and measurement technique. Most studies measured BCRL based on differences in arm circumference (n = 18) or by self-reported symptoms (n = 18). The weighted average of BCRL incidence following ALND measured by self-report and circumference method was 28% and 16%, respectively. The importance of ALND and irradiation as part of the treatment of operable breast carcinoma is well established, but its morbidity is less well documented. We argue self-report as the most appropriate method to -establish a diagnosis of BCRL. Therefore a 28% risk of finding non-sentinel lymph node metastases in a completion ALND will be regarded as the cut-off in a medical decision to proceed with ALND.